(2)
Represents 38,750 unexercisable shares underlying the unexercised stock option granted to Mr. Cooper on January 22, 2019, entitling him to purchase an aggregate of 124,000 shares of our common stock. The stock option vested and become exercisable as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.
(3)
Represents the unexercised stock option granted to Mr. Cooper on January 21, 2021, entitling him to purchase an aggregate of 93,000 shares of our common stock. The stock option vested and became exercisable as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
(4)
Represents the unvested portion of 48,700 RSUs granted to Mr. Cooper on January 21, 2021, each of which represents the right to receive one share of common stock upon vesting. The RSUs vested as to 25% of the shares on January 21, 2022 with the remainder vesting in equal installments every three months thereafter, beginning on April 21, 2022 and ending on January 21, 2025.
(5)
Represents 9,375 unexercisable stock option granted to Mr. Harford on October 10, 2018, entitling him to purchase an aggregate of 37,500 shares of our common stock. The stock option vested and became exercisable as to 25% of the shares on October 10, 2019, with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022.
(6)
Represents 9,844 unexercisable shares underlying the unexercised stock option granted to Mr. Harford on January 22, 2019, entitling him to purchase an aggregate of 31,500 shares of our common stock. The stock option vested and become exercisable as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.
(7)
Represents the unexercised stock option granted to Mr. Harford on January 21, 2021, entitling him to purchase an aggregate of 23,700 shares of our common stock. The stock option vested and became exercisable as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
(8)
Represents the unvested portion of 5,000 RSUs granted to Mr. Harford on October 10, 2018, each of which represents the right to receive one share of common stock upon vesting. The RSUs vested as to 25% of the shares on October 10, 2019 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022.
(9)
Represents the unvested portion of 5,500 RSUs granted to Mr. Harford on January 21, 2021, each of which represents the right to receive one share of common stock upon vesting. The RSUs vested as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
(10)
Represents 3,751 unexercisable shares underlying the unexercised stock option granted to Ms. Carter on June 8, 2018, entitling her to purchase an aggregate of 30,000 shares of our common stock. The stock option vested and became exercisable as to 25% of the shares on June 7, 2019 with the remainder vesting and becoming exercisable in 12 equal installments on the 7th day of each calendar quarter beginning with September 7, 2019 and ending on June 7, 2022.
(11)
Represents 9,844 unexercisable shares underlying the unexercised stock option granted to Ms. Carter on January 22, 2019, entitling her to purchase an aggregate of 31,500 shares of our common stock. The stock option was exercised as to 11,812 shares in September 2020, leaving 19,688 shares underlying the unexercised stock option. The stock option vested and became exercisable as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.
(12)
Represents the unexercised stock option granted to Ms. Carter on January 21, 2021, entitling her to purchase an aggregate of 23,700 shares of our common stock. The stock option vested and became exercisable as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
(13)
Represents the unvested portion of 5,500 RSUs granted to Ms. Carter on January 21, 2021, each of